2021-01-02,b'2/2\n\n$INBX $KNTE $KURA $MRSN $NKTX $NRIX $OLMA $ONCT $PASG $PMVP $PRLD $PTGX $RPTX $RCKT $SRRK $MCRB $SGTX $SBTX \n\nIf you\xe2\x80\x99re an expert in the field and see something you dont like please DM me.'
2021-01-02,b'$BEAM\n$NTLA\n$STOK\n$DCCC\n$NRIX\n$KYMR\n$FDMT\n$KNTE\n$BDTX\n$ITOS\n$MORF\n$TSHA\n$GBIO\n$FREQ\n$ORIC\n$DNLI\n$RPTX\n$PHAT?\n$SBTX\n$AVIR\n$PMVP\n$PRLD\n\nAn early list of bloated stocks that could fit this category. No position'
2021-01-02,b'My 2021 Picks https://t.co/34Spy8twym\n7 day record data for the blog. Not too shabby given the only new material was posted 13 hours ago. \n$ORPH\n$SNG\n$SBTX\n$DDDD\n$OPTI\n$AVA\n\n$PHE\nTop articles. https://t.co/OP1mQGxncS'
2021-01-02,b'RT @thebubbleboard: Thu Dec 31\nGaining #stocks this afternoon:\n\n$BTBT: +45.9%\n$IPI: +41.4%\n$BNGO: +37.1%\n$LC: +31.6%\n$SGTX: +28.9%\n$EBON: +\xe2\x80\xa6'
2021-01-01,b'RT @LuoshengPeng: Another blooding day for most gwth stocks while we see these outlier winners:\n\n$BTBT 47% $CAN 42%\n$BNGO 39% $SBTX 17% $OD\xe2\x80\xa6'
2020-12-31,b'RT @thebubbleboard: Thu Dec 31\nGaining #stocks this afternoon:\n\n$BTBT: +45.9%\n$IPI: +41.4%\n$BNGO: +37.1%\n$LC: +31.6%\n$SGTX: +28.9%\n$EBON: +\xe2\x80\xa6'
2020-12-31,"b'Stocks in New High today: $SBTX, Current Price: $46.53, Change today: 11.82%, Total Traded Volume: 127,386 https://t.co/jaYXYYNgj8'"
2020-12-31,b'RT @LuoshengPeng: Another blooding day for most gwth stocks while we see these outlier winners:\n\n$BTBT 47% $CAN 42%\n$BNGO 39% $SBTX 17% $OD\xe2\x80\xa6'
2020-12-31,b'Another blooding day for most gwth stocks while we see these outlier winners:\n\n$BTBT 47% $CAN 42%\n$BNGO 39% $SBTX 17% $ODT 11% $RNLX 11% $TRIL 10%\n$BEEM 8%\n$PIC 28%\n\nCongrats if you own any of the tickets!\n\nAttached are ARK funds for you to see where stocks are getting hit most. https://t.co/OxmZaKbl9h'
2020-12-31,b'Thu Dec 31\nGaining #stocks this afternoon:\n\n$BTBT: +45.9%\n$IPI: +41.4%\n$BNGO: +37.1%\n$LC: +31.6%\n$SGTX: +28.9%\n$EBON: +24.2%\n$GCI: +17.2%\n$CELH: +14.0%\n$SBTX: +12.1%\n\nclick here for a visual version:\nhttps://t.co/DIm5R29Mz3 https://t.co/qAnlAftcVg'
2020-12-31,b'New 52 Week High today: $SBTX $EWEB $DFS $GS $WILC $CBON $DMRE ... https://t.co/4Iw0QeR3p8'
2020-12-31,"b'Daily #Biotech Pulse: Osmotica Faces 2nd FDA Rejection, UK Cond. Approves AstraZenecavVaccine Candidate, Hepion NASH Data.. New Highs: $ABMD $APLS $AVIR $BASI $BNGO $CLPT $DMTK $EW $NARI $LUMO $MRSN $ORGO $PRAX $SBTX $SPRO $TENX $TCON $TMDI $UTHR $XTLB \nhttps://t.co/yvLqLV6i5H'"
2020-12-31,"b'RT @bti_trading: $AYM $SBTX $PHE 15m\n We cover all asset classes and many timeframes\nInternationals stocks, indices, futures, cryptos, fore\xe2\x80\xa6'"
2020-12-30,b'BioPharmCatalyst updates 12/30/20:\n\n$AZN U.K. COVID-19 vaccine approval\n$KALV +21% (data 1Q 21)\n$SBTX analyst initiations (Tue) +14%\n\n$NOVN +50%; $AZRX +33%\n$OSMT -20%; $CYCC -13%\n\nPipeline updates $ALT $CDAK $PLX\n\nhttps://t.co/HU1TX3dr9X'
2020-12-30,b'Scan results - Stochastic Sell Signal today: $CEO $ORIC $APSG $UBSI $MSFT $ENR $KR $ABB $EW $SBTX $KDP $ELAN ... https://t.co/NoWdsjqZiW'
2020-12-30,b'$SBTX - Silverback Therapeutics is a buy at Goldman Sachs on unique therapy platform https://t.co/c84NHIF0N3'
2020-12-30,"b'Our #equityresearch team has initiated coverage on $SBTX, a #lifesciences company focused on developing targeted #immunooncology agents. Review our\ncoverage universe here: https://t.co/mZFKJKOPNQ https://t.co/hjoc2183Gy'"
2020-12-30,b'New 52 Week High today: $SBTX $EBLU $ISDX $EMXC $SGOC ... https://t.co/4Iw0QeR3p8'
2020-12-30,b'$SGTX Barclays Overweight $48 \n$SBTX SVB Leerink Outperform $40 \n$INFU Sidoti Buy $26'
2020-12-30,b'$SBTX Goldman Buy $43 \n$SEER Morgan Stanley Equal-Weight $65 \n$SEER Cowen Outperform \n$SEER BofA Securities Neutral $69 \n$SEER JP Morgan Overweight $75 \n$SGTX Morgan Stanley Equal-Weight $45 \n$SGTX Jefferies Buy $60 \n$SPLK Daiwa Securities Neutral $189 \n$YQ Goldman Buy $21'
2020-12-30,"b'$AYM $SBTX $PHE 15m\n We cover all asset classes and many timeframes\nInternationals stocks, indices, futures, cryptos, forex, and commodities .\nWe\xf0\x9f\x98\x8d our algorithm on BRITISH #stocks !\n\n#stocks #bti #LSE $FTSE #UK100\n\nRequest your trial for 10\xe2\x82\xac only: https://t.co/ptEoRUsdva https://t.co/rVoWZQtlQy'"
2020-12-30,"b'$SBTX SVB Leerink Bullish On Silverback Therapeutics, Sees Diverse Pipeline https://t.co/x8CZYmOZka'"
2020-12-29,"b'$SBTX Silverback Therapeutics Gets Buy Ratings From HC Wainwright ($44 PT ), Stifel ($58 PT) and Goldman Sachs ($43 PT) https://t.co/Yd3TlGmMf1'"
2020-12-29,"b'$SBTX latest ratings on 2020-12-29 at Stock Target Advisor https://t.co/nk1esfUUxV : Stifel Nicolaus (Initiated by), HC Wainwright (Initiated by), Goldman Sachs (Initiated by), SVB Leerink (Initiated by)'"
2020-12-29,b'$SBTX \nInitiated by Stifel Nicolaus Buy USD 58 \nInitiated by HC Wainwright Buy USD 44 \nInitiated by Goldman Sachs Buy USD 43\nInitiated by SVB Leerink Outperform USD 40\nhttps://t.co/W8tb2TO8lY'
2020-12-29,"b""Splunk initiation, Snap target change among today's top calls on Wall Street $SPLK $SNAP $ARCT $OLED $SBTX https://t.co/mhh4RcGxkc"""
2020-12-29,"b""Splunk initiation, Snap target change among today's top calls on Wall Street\n$SPLK $SNAP $ARCT $OLED $SBTX"""
2020-12-29,b'Fly Intel: Top five analyst calls $CLR $ARCT $APRE $SBTX $SEER https://t.co/1svis2mG7i'
2020-12-29,"b'Biggest upside analyst calls of the day, not for the timid:\n$SNAP 45% to Goldman $70 tgt\n$SBTX 57% to Stifel $58 tgt\n$SGTX 41% to Jefferies $60 tgt\n$BYSI +170% to Evercore $30 tgt'"
2020-12-29,b'Silverback Therapeutics initiated with an Outperform at SVB Leerink\n$SBTX'
2020-12-29,"b'$SBTX Leerink initiates with Outperform, PT 40'"
2020-12-29,b'RT @OxAnalyst: $SBTX initiated at Stifel (PT $58) and Goldman (PT $43)\n\nImmunoconjugate assets (+TLR8 agonist payloads):\nSBT6050: HER2 mAb\xe2\x80\xa6'
2020-12-29,b'$PFE\nPFE Reiterated by Royal Bank of Canada with price target 42 and rating Neutral\nSource:https://t.co/cLuXiVHuP1\n\n$SBTX\nSBTX Initiated by HC Wainwright with price target 44 and rating Buy | SBTX Initiated by The Go... https://t.co/epNXRAxccE'
2020-12-29,b'RT @OxAnalyst: $SBTX initiated at Stifel (PT $58) and Goldman (PT $43)\n\nImmunoconjugate assets (+TLR8 agonist payloads):\nSBT6050: HER2 mAb\xe2\x80\xa6'
2020-12-29,b'SVB Leerink Initiates Coverage On Silverback Therapeutics with Outperform Rating\n\nRelated Tickers: $SBTX\nRead more at: https://t.co/sKtJGWK8ei'
2020-12-29,b'STIFEL $SBTX Initiating Coverage with a Buy Rating &amp; $58 TP'
2020-12-29,"b'Stifel Initiates Coverage On Silverback Therapeutics with Buy Rating, Announces Price Target of $58\n\nRelated Tickers: $SBTX\nRead more at: https://t.co/xmMcqXRy6z'"
2020-12-29,"b""$SBTX initiated at Stifel (PT $58) and Goldman (PT $43)\n\nImmunoconjugate assets (+TLR8 agonist payloads):\nSBT6050: HER2 mAb\nSBT6290: Nectin4 mAb\n\nInitial '6050 Ph1 monotx data at *0.3mg/kg (update 2H21):\n-NSCLC pt. \xe2\x89\xa530% reduction (8 wks)\n-BC pt. with SD (16 wks)\n\n*below MPAD https://t.co/Q3awHQHVk5"""
2020-12-29,b'$SBTX: H.C. Wainwright starts at Buy'
2020-12-29,b'$SBTX  SILVERBACK THERAPEUTICS INC  SBTX.O: STIFEL STARTS WITH BUY RATING; PRICE TARGET $58'
2020-12-29,b'Silverback Therapeutics initiated with a Buy at Stifel\n$SBTX'
2020-12-29,"b'HC Wainwright &amp; Co. Initiates Coverage On Silverback Therapeutics with Buy Rating, Announces Price Target of $44\n\nRelated Tickers: $SBTX\nRead more at: https://t.co/TwC7vJhmh9'"
2020-12-29,b'Silverback Therapeutics initiated with a Buy at H.C. Wainwright\n$SBTX'
2020-12-29,b'Silverback Therapeutics initiated with a Buy at Goldman Sachs\n$SBTX'
2020-12-29,"b'$SBTX Stifel initiates with Buy, PT 58'"
2021-01-08,b'RT @LEMMINGINVESTOR: The Barking Mad Blogger - OptiBiotix &amp; SkinBioTher... https://t.co/f9c2QWwNCV \n\nBoth $OPTI and $SBTX looking hot. $SBT\xe2\x80\xa6'
2021-01-08,b'The Barking Mad Blogger - OptiBiotix &amp; SkinBioTher... https://t.co/f9c2QWwNCV \n\nBoth $OPTI and $SBTX looking hot. $SBTX threatens the breach the all-time high of 30p for a 4th time.'
2021-01-07,b'RT @KeshavjeeYusuf: Huge upside today well done Stuart Ashman\n$SBTX SkinBioTherapeutics preparing to kick off psoriasis study as it eyes a\xe2\x80\xa6'
2021-01-07,b'Huge upside today well done Stuart Ashman\n$SBTX SkinBioTherapeutics preparing to kick off psoriasis study as it eyes a busy year https://t.co/OnoUqnRgrg  @SkinBioT #SBTX'
